Time from Prior Chemotherapy Enhances Prognostic Risk Grouping in the Second-line Setting of Advanced Urothelial Carcinoma: A Retrospective Analysis of Pooled, Prospective Phase 2 Trials

Guru Sonpavde; Gregory R Pond; Ronan Fougeray; Toni K Choueiri; Angela Q Qu; David J Vaughn; Guenter Niegisch; Peter Albers; Nicholas D James; Yu-Ning Wong; Yoo-Joung Ko; Srikala S Sridhar; Matthew D Galsky; Daniel P Petrylak; Ulka N Vaishampayan; Awais Khan; Nicholas J Vogelzang; Tomasz M Beer; Walter M Stadler; Peter H O'Donnell; Cora N Sternberg; Jonathan E Rosenberg; Joaquim Bellmunt

doi:10.1016/j.eururo.2012.11.042

Time from Prior Chemotherapy Enhances Prognostic Risk Grouping in the Second-line Setting of Advanced Urothelial Carcinoma: A Retrospective Analysis of Pooled, Prospective Phase 2 Trials

Guru Sonpavde, Gregory R Pond, Ronan Fougeray, Toni K Choueiri, Angela Q Qu, David J Vaughn, Guenter Niegisch, Peter Albers, Nicholas D James, Yu-Ning Wong, Yoo-Joung Ko, Srikala S Sridhar, Matthew D Galsky, Daniel P Petrylak, Ulka N Vaishampayan, Awais Khan, Nicholas J Vogelzang, Tomasz M Beer, Walter M Stadler, Peter H O'DonnellCora N Sternberg, Jonathan E Rosenberg, Joaquim Bellmunt

Cancer and Genomic Sciences

Research output: Contribution to journal › Article › peer-review

78 Citations (Scopus)

Abstract

BACKGROUND: Outcomes for patients in the second-line setting of advanced urothelial carcinoma (UC) are dismal. The recognized prognostic factors in this context are Eastern Cooperative Oncology Group (ECOG) performance status (PS) >0, hemoglobin level (Hb) 0, LM, Hb 0, Hb

Original language	English
Journal	European urology
DOIs	https://doi.org/10.1016/j.eururo.2012.11.042
Publication status	Published - 2012

Access to Document

10.1016/j.eururo.2012.11.042

Cite this

Sonpavde, G., Pond, G. R., Fougeray, R., Choueiri, T. K., Qu, A. Q., Vaughn, D. J., Niegisch, G., Albers, P., James, N. D., Wong, Y.-N., Ko, Y.-J., Sridhar, S. S., Galsky, M. D., Petrylak, D. P., Vaishampayan, U. N., Khan, A., Vogelzang, N. J., Beer, T. M., Stadler, W. M., ... Bellmunt, J. (2012). Time from Prior Chemotherapy Enhances Prognostic Risk Grouping in the Second-line Setting of Advanced Urothelial Carcinoma: A Retrospective Analysis of Pooled, Prospective Phase 2 Trials. European urology. https://doi.org/10.1016/j.eururo.2012.11.042

@article{7be9f344adba45feadd5ad3159e184e6,

title = "Time from Prior Chemotherapy Enhances Prognostic Risk Grouping in the Second-line Setting of Advanced Urothelial Carcinoma: A Retrospective Analysis of Pooled, Prospective Phase 2 Trials",

abstract = "BACKGROUND: Outcomes for patients in the second-line setting of advanced urothelial carcinoma (UC) are dismal. The recognized prognostic factors in this context are Eastern Cooperative Oncology Group (ECOG) performance status (PS) >0, hemoglobin level (Hb) 0, LM, Hb 0, Hb ",

author = "Guru Sonpavde and Pond, {Gregory R} and Ronan Fougeray and Choueiri, {Toni K} and Qu, {Angela Q} and Vaughn, {David J} and Guenter Niegisch and Peter Albers and James, {Nicholas D} and Yu-Ning Wong and Yoo-Joung Ko and Sridhar, {Srikala S} and Galsky, {Matthew D} and Petrylak, {Daniel P} and Vaishampayan, {Ulka N} and Awais Khan and Vogelzang, {Nicholas J} and Beer, {Tomasz M} and Stadler, {Walter M} and O'Donnell, {Peter H} and Sternberg, {Cora N} and Rosenberg, {Jonathan E} and Joaquim Bellmunt",

year = "2012",

doi = "10.1016/j.eururo.2012.11.042",

language = "English",

journal = "European urology",

publisher = "Elsevier",

}

Sonpavde, G, Pond, GR, Fougeray, R, Choueiri, TK, Qu, AQ, Vaughn, DJ, Niegisch, G, Albers, P, James, ND, Wong, Y-N, Ko, Y-J, Sridhar, SS, Galsky, MD, Petrylak, DP, Vaishampayan, UN, Khan, A, Vogelzang, NJ, Beer, TM, Stadler, WM, O'Donnell, PH, Sternberg, CN, Rosenberg, JE & Bellmunt, J 2012, 'Time from Prior Chemotherapy Enhances Prognostic Risk Grouping in the Second-line Setting of Advanced Urothelial Carcinoma: A Retrospective Analysis of Pooled, Prospective Phase 2 Trials', European urology. https://doi.org/10.1016/j.eururo.2012.11.042

TY - JOUR

T1 - Time from Prior Chemotherapy Enhances Prognostic Risk Grouping in the Second-line Setting of Advanced Urothelial Carcinoma

T2 - A Retrospective Analysis of Pooled, Prospective Phase 2 Trials

AU - Sonpavde, Guru

AU - Pond, Gregory R

AU - Fougeray, Ronan

AU - Choueiri, Toni K

AU - Qu, Angela Q

AU - Vaughn, David J

AU - Niegisch, Guenter

AU - Albers, Peter

AU - James, Nicholas D

AU - Wong, Yu-Ning

AU - Ko, Yoo-Joung

AU - Sridhar, Srikala S

AU - Galsky, Matthew D

AU - Petrylak, Daniel P

AU - Vaishampayan, Ulka N

AU - Khan, Awais

AU - Vogelzang, Nicholas J

AU - Beer, Tomasz M

AU - Stadler, Walter M

AU - O'Donnell, Peter H

AU - Sternberg, Cora N

AU - Rosenberg, Jonathan E

AU - Bellmunt, Joaquim

PY - 2012

Y1 - 2012

N2 - BACKGROUND: Outcomes for patients in the second-line setting of advanced urothelial carcinoma (UC) are dismal. The recognized prognostic factors in this context are Eastern Cooperative Oncology Group (ECOG) performance status (PS) >0, hemoglobin level (Hb) 0, LM, Hb 0, Hb

AB - BACKGROUND: Outcomes for patients in the second-line setting of advanced urothelial carcinoma (UC) are dismal. The recognized prognostic factors in this context are Eastern Cooperative Oncology Group (ECOG) performance status (PS) >0, hemoglobin level (Hb) 0, LM, Hb 0, Hb

U2 - 10.1016/j.eururo.2012.11.042

DO - 10.1016/j.eururo.2012.11.042

M3 - Article

C2 - 23206856

JO - European urology

JF - European urology

ER -

Time from Prior Chemotherapy Enhances Prognostic Risk Grouping in the Second-line Setting of Advanced Urothelial Carcinoma: A Retrospective Analysis of Pooled, Prospective Phase 2 Trials

Abstract

Access to Document

Fingerprint

Cite this